Beyond C4d: Other complement-related diagnostic approaches to antibody-mediated rejection

被引:59
作者
Baldwin, WM [1 ]
Kasper, EK
Zachary, AA
Wasowska, BA
Rodriguez, ER
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
关键词
antibodies; complement; complement receptors; transplant rejection;
D O I
10.1111/j.1600-6143.2004.00348.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Complement is a multifunctional system of receptors and regulators as well as effector molecules. Both the pathogenic and diagnostic power of complement is based on the capacity of the complement system to amplify innate and adaptive immunity. This amplification is accomplished through two strategies: (1) enzymatic reactions in the complement cascade, and (2) stimulation of leukocytes, platelets and parenchymal cells through specific receptors or receptor-independent pore formation. The mechanisms by which complement mediates and modifies nonspecific inflammation, antibody-mediated injury and T-cell responses are of particular significance to the pathogenesis of transplant rejection. Understanding the mechanisms by which complement integrates the interactions of leukocytes, platelets and parenchymal cells offers opportunities to further refine the diagnosis of rejection.
引用
收藏
页码:311 / 318
页数:8
相关论文
共 69 条
  • [1] Complement as a mediator of vascular inflammation and activation in allografts
    Baldwin, WM
    Qian, ZP
    Ota, H
    Samaniego, M
    Wasowska, B
    Sanfilippo, F
    Hruban, RH
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (08) : 723 - 730
  • [2] Complement in transplant rejection: diagnostic and mechanistic considerations
    Baldwin, WM
    Ota, H
    Rodriguez, ER
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2003, 25 (02): : 181 - 197
  • [3] Innate immune responses to transplants: A significant variable with cadaver donors
    Baldwin, WM
    Larsen, CP
    Fairchild, RL
    [J]. IMMUNITY, 2001, 14 (04) : 369 - 376
  • [4] BALDWIN WM, 2003, AM J TRANSPL, V5, P195
  • [5] Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells
    Barilla-LaBarca, ML
    Liszewski, MK
    Lambris, JD
    Hourcade, D
    Atkinson, JP
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (12) : 6298 - 6304
  • [6] ASSESSMENT OF SOLUBLE ADHESION MOLECULES (SICAM-1, SVCAM-1, SELAM-1) AND COMPLEMENT CLEAVAGE PRODUCTS (SC4D, SC5B-9) IN URINE - CLINICAL MONITORING OF RENAL-ALLOGRAFT RECIPIENTS
    BECHTEL, U
    SCHEUER, R
    LANDGRAF, R
    KONIG, A
    FEUCHT, HE
    [J]. TRANSPLANTATION, 1994, 58 (08) : 905 - 911
  • [7] TERMINAL COMPLEMENT PROTEINS C5B-9 RELEASE BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR FROM ENDOTHELIAL-CELLS
    BENZAQUEN, LR
    NICHOLSONWELLER, A
    HALPERIN, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) : 985 - 992
  • [8] Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
    Botto, M
    Dell'Agnola, C
    Bygrave, AE
    Thompson, EM
    Cook, HT
    Petry, F
    Loos, M
    Pandolfi, PP
    Walport, MJ
    [J]. NATURE GENETICS, 1998, 19 (01) : 56 - 59
  • [9] PREDICTIVE VALUE OF INDUCIBLE ENDOTHELIAL-CELL ADHESION MOLECULE EXPRESSION FOR ACUTE REJECTION OF HUMAN CARDIAC ALLOGRAFTS
    BRISCOE, DM
    YEUNG, AC
    SCHOEN, EL
    ALLRED, EN
    STAVRAKIS, G
    GANZ, P
    COTRAN, RS
    POBER, JS
    [J]. TRANSPLANTATION, 1995, 59 (02) : 204 - 211
  • [10] CARNEY DF, 1985, J IMMUNOL, V134, P1804